Tradewinds LLC’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$661K Sell
4,435
-1
-0% -$140 0.14% 107
2026
Q2
$560K Hold
4,436
– – 0.13% 115
2026
Q1
$584K Buy
4,436
+107
+2% +$15K 0.19% 72
2025
Q4
$531K Sell
4,329
-238
-5% -$28.9K 0.13% 107
2025
Q3
$507K Buy
4,567
+30
+0.7% +$3.41K 0.12% 111
2025
Q1
$508K Sell
4,537
-159
-3% -$16.4K 0.14% 115
2024
Q4
$450K Sell
4,696
-490
-9% -$44.1K 0.13% 127
2024
Q3
$435K Sell
5,186
-279
-5% -$21.3K 0.13% 120
2024
Q2
$375K Sell
5,465
-262
-5% -$17.5K 0.12% 137
2023
Q3
$429K Sell
5,727
-70
-1% -$5.38K 0.25% 68
2023
Q2
$447K Buy
5,797
+121
+2% +$9.6K 0.26% 67
2023
Q1
$471K Buy
5,676
+268
+5% +$22.2K 0.29% 67
2022
Q4
$464K Sell
5,408
-169
-3% -$13.4K 0.3% 63
2022
Q3
$344K Buy
5,577
+1,004
+22% +$63.3K 0.25% 78
2022
Q2
$283K Hold
4,573
– – 0.19% 91

Other funds holding GILD

Tradewinds LLC's GILD Position: Q3 2026 in Review

Tradewinds LLC reduced its Gilead Sciences (GILD) stake by 0.02% in Q3 2026, selling an estimated $140 and leaving 4,435 shares worth $661K. The position accounts for 0.14% of the portfolio, ranked #107.

Tradewinds LLC first reported a position in GILD in Q2 2022 and has held it in 15 quarters since. 2,354 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Tradewinds LLC held 4,435 shares of Gilead Sciences worth $661K as of Q3 2026.
  • Tradewinds LLC sold 1 Gilead Sciences share in Q3 2026, an estimated $140.
  • Gilead Sciences made up 0.14% of Tradewinds LLC's portfolio in Q3 2026, its #107 holding.
  • Tradewinds LLC first reported a position in Gilead Sciences in Q2 2022 and has held it in 15 quarters since.
  • 2,354 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Tradewinds LLC's 13F filing for Q3 2026, filed 19 Nov 2026.